Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death

Attorneys are reviewing potential Omnipod 5 lawsuits to determine whether design, testing or warning failures caused dangerous dosing errors and injuries.

Following a recent recall of Insulet Omnipod 5 insulin pumps, due to a risk of dosing errors that may be caused by a design or manufacturing defect, attorneys are now investigating lawsuits for individuals who experienced diabetic ketoacidosis or other serious injuries linked to inaccurate insulin delivery.

The Insulet Omnipod 5 recall was announced by the U.S. Food and Drug Administration (FDA) on March 18, involving a substantial number of pods distributed to consumers nationwide in recent weeks.

According to regulators, the issue may involve damage to an internal component that controls insulin delivery, which can result in both under-delivery and over-delivery of insulin, disrupting blood glucose levels and increasing the risk of medical emergencies.

Federal regulators have confirmed at least 18 reports of serious injuries tied to the defective pods. For individuals with diabetes, particularly those with Type 1 diabetes who rely on precise insulin dosing, even minor disruptions can quickly escalate into life-threatening conditions requiring emergency treatment.

In the aftermath of the recall, Omnipod injury lawyers are now investigating whether the manufacturer failed to properly design, test, or warn about the risk of insulin delivery failures associated with the pods.

Omnipod 5 Insulin Pods Recall

Insulet Corporation issued an urgent medical device correction on March 12, 2026, affecting approximately 1.5% of Omnipod 5 pods distributed annually by the company. The action followed at least 18 reported injuries, including cases of severe hyperglycemia, diabetic ketoacidosis and hospitalizations linked to insulin delivery problems.

The recall has been traced to a defect in the pod’s internal tubing system, a critical component responsible for delivering insulin from the reservoir into the body. According to the manufacturer, some pods may develop a small tear in this tubing, which can interfere with the normal flow of insulin during use.

When this occurs, insulin may be delivered inconsistently or not at all, even though the device may appear to be functioning properly. Because the Omnipod 5 system is designed to automatically deliver insulin over a period of up to 72 hours, users may not immediately recognize that dosing has been disrupted.

Even short interruptions in insulin delivery can cause blood glucose levels to rise rapidly, particularly for individuals with insulin-dependent diabetes. If not detected in time, this can lead to serious complications, including diabetic ketoacidosis, hospitalization or other life-threatening events.

Insulin Delivery Failure

Among the most serious risks associated with defective insulin delivery systems are diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), both of which are acute medical emergencies caused by extreme hyperglycemia and insufficient insulin levels.

Diabetic ketoacidosis (DKA) occurs when the body does not have enough insulin to allow glucose to enter cells for energy. As a result, the body begins breaking down fat, producing ketones that build up in the bloodstream and make the blood more acidic. The condition is most common among individuals with Type 1 diabetes and can develop rapidly, sometimes within hours.

Symptoms may include nausea, vomiting, abdominal pain, confusion, rapid breathing and a distinct fruity odor on the breath caused by elevated ketone levels. Without prompt treatment, DKA can lead to severe dehydration, organ failure and death.

Hyperosmolar hyperglycemic state (HHS), which more commonly affects individuals with Type 2 diabetes, involves extremely high blood sugar levels without the same level of ketone production seen in DKA. However, HHS can lead to profound dehydration, increased blood osmolarity and altered consciousness, including seizures or coma.

Both DKA and HHS require immediate medical treatment, typically involving aggressive fluid replacement, correction of electrolyte imbalances and administration of insulin to stabilize blood glucose levels. Hospitalization is often necessary and delayed treatment can significantly increase the risk of long-term complications or fatal outcomes.

In the most severe cases, disruptions in insulin delivery caused by defective pods may lead to diabetic coma or death.

Insulet Omnipod 5 Lawsuits

Following the recall and reports of injuries, attorneys are actively investigating potential Insulet Omnipod 5 lawsuits on behalf of individuals who suffered complications after using the defective insulin pods.

These cases will focus on whether the manufacturer failed to make the device safe and reliable, and whether defects, such as the reported tubing tears, made it dangerous to use.

Individuals who experienced any of the following symptoms after using an Omnipod 5 pod may be eligible to pursue compensation for medical expenses, pain and suffering, and other damages:

• Diabetic ketoacidosis (DKA)
• Hyperosmolar hyperglycemic state (HHS)
• Hospitalization
• Diabetic coma
• Other serious complications

Omnipod 5 lawyers offer free consultations and work on a contingency fee basis, meaning there are no upfront costs unless compensation is recovered.

Sign up for more safety and legal news that could affect you or your family.